JPRN-UMIN000032266招募中未知
Evaluation of drug-drug interaction between cytochrome P450 substrate Selexipag and Clopidogrel in human - Drug-drug interaction between Selexipag and Clopidogrel
Hamamatsu University School of Medicine, Clinical Pharmacology and Therapeutics0 个研究点目标入组 15 人开始时间: 2018年4月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1 subject who takes medicine 1 week before each 1st and 2nd PK trial 2 subject who has apparent abnormality in advance blood and biochemical examinations 3 subject who were judged to be not eligible in this study by the physician in chrage
研究者
相似试验
尚未招募
Unknown
Study of how pain relieving medications (opioids) can affect or be affected by other medications in cancer patients with paiCTRI/2024/06/068387Kasturba Medical College Manipal
已完成
不适用
Clinical Analysis of drug inTEraction between CatecHin and Ixazomib for patieNts with multiple myelomaMultiple myelomaJPRN-UMIN000031235Kobe University Hospital20
已完成
2 期
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.Metastatic castration-resistant prostate cancer10038597NL-OMON50053Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
不适用
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.NL-OMON28448Erasmus MC17
进行中（未招募）
1 期
Study on the interaction between cabazitaxel and darolutamide in patients with metastatic prostate cancermetastatic castration-resistant prostate cancerEUCTR2020-000823-38-NLErasmus MC Cancer Institute17